These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18462814)

  • 21. Short communication. Antiretroviral drug resistance among drug-naive HIV-1-infected individuals in Djibouti (Horn of Africa).
    Maslin J; Rogier C; Caron M; Grandadam M; Koeck JL; Nicand E
    Antivir Ther; 2005; 10(7):855-9. PubMed ID: 16312182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
    Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
    Vergne L; Stuyver L; Van Houtte M; Butel C; Delaporte E; Peeters M
    J Clin Virol; 2006 May; 36(1):43-9. PubMed ID: 16563858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients.
    Youle M
    J Antimicrob Chemother; 2007 Dec; 60(6):1195-205. PubMed ID: 17890281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
    Witvrouw M; Pannecouque C; Switzer WM; Folks TM; De Clercq E; Heneine W
    Antivir Ther; 2004 Feb; 9(1):57-65. PubMed ID: 15040537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy.
    Schmidt B; Walter H; Zeitler N; Korn K
    AIDS Rev; 2002; 4(3):148-56. PubMed ID: 12416449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-drug resistant HIV-1 reverse transcriptase genotype in children treated with dual nucleoside reverse transcriptase inhibitors (NRTIs).
    Engchanil C; Kosalaraksa P; Lulitanond V; Lumbiganon P; Chantratita W
    J Med Assoc Thai; 2006 Oct; 89(10):1713-20. PubMed ID: 17128848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations.
    Scudeller L; Torti C; Quiros-Roldan E; Patroni A; Lo Caputo S; Moretti F; Mazzotta F; Donati E; Vivarelli A; Carosi G;
    J Antimicrob Chemother; 2003 Nov; 52(5):776-81. PubMed ID: 14563897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
    Sukasem C; Churdboonchart V; Sukeepaisarncharoen W; Piroj W; Inwisai T; Tiensuwan M; Chantratita W
    Int J Antimicrob Agents; 2008 Mar; 31(3):277-81. PubMed ID: 18182278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
    Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
    Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.
    Soulié C; Assoumou L; Ghosn J; Duvivier C; Peytavin G; Ait-Arkoub Z; Molina JM; Costagliola D; Katlama C; Calvez V; Marcelin AG
    AIDS; 2009 Jul; 23(12):1605-8. PubMed ID: 19487903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks.
    Kjaer J; Høj L; Fox Z; Lundgren JD
    HIV Med; 2008 Oct; 9(8):642-52. PubMed ID: 18631257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms.
    Cotte L; Trabaud MA; Tardy JC; Brochier C; Gilibert RP; Miailhes P; Trépo C; André P
    J Med Virol; 2009 Apr; 81(4):672-7. PubMed ID: 19235860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
    Acevedo W; Gallardo AM; Galaz J; Afani A; Cortés E
    Rev Med Chil; 2007 Nov; 135(11):1406-13. PubMed ID: 18259651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.
    Kijak GH; Rubio AE; Pampuro SE; Zala C; Cahn P; Galli R; Montaner JS; Salomón H
    HIV Med; 2003 Jan; 4(1):72-8. PubMed ID: 12534963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple linear model provides highly accurate genotypic predictions of HIV-1 drug resistance.
    Wang K; Jenwitheesuk E; Samudrala R; Mittler JE
    Antivir Ther; 2004 Jun; 9(3):343-52. PubMed ID: 15259897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
    Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.